A Study Comparing GB241 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma

Clinical trial NCT03003039 · COMPLETED

Trial details

NCT number: NCT03003039
Sponsor: Nanjing Yoko Biomedical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B-Cell Lymphoma

Start date: 2017-06-05
Primary completion: 2019-05-20
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.